Stitzer H. Todd
Known title: DirectorCIK: 0001538896
Associated companies
Transaction History
| SIG | ▼ Sell | Open Market | 10,000 | $1.0M | 4/22/2024 | View on chart |
| SIG | ▼ Sell | Open Market | 5,000 | $500K | 4/10/2024 | View on chart |
| SIG | ▼ Sell | Open Market | 5,000 | $512K | 4/9/2024 | View on chart |
| SIG | ▲ Buy | Grant | 3,700 | $0 | 6/16/2023 | View on chart |
| SIG | ▲ Buy | Grant | 4,000 | $0 | 6/17/2022 | View on chart |
| SIG | ▼ Sell | Open Market | 15,083 | $1.3M | 10/18/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Signet Shares Rise 8.4% Post-Earnings; Blue Nile Partners with Royal Asscher
Signet shares have climbed 8.4% since the last earnings report, moving against a broader market dip. The company also announced that its Blue Nile brand is partnering with Royal Asscher, a move that may strengthen its product lineup. With an average analyst target of $125.90, the stock remains well below that level, sitting near its 52-week high of $110.20.
Signet Shares Rise 8.4% Post-Earnings; Blue Nile Partners with Royal Asscher. Signet shares have climbed 8.4% since the last earnings report, moving against a broader market dip. The company also announced that its Blue Nile brand is partnering with Royal Asscher, a move that may strengthen its product lineup. With an average analyst target of $125.90, the stock remains well below that level, sitting near its 52-week high of $110.20.